Replies to post #104072 on Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

Just to confirm my impression of the HOT data released this morning, I asked Dennis (aka biotech2k on IV) to comment on the data. He posted the following:
"The best response is Stable Disease? I see no CR or no PR. That means the official RECIST 1.1 ORR is 0% and the Clinical Benefit Rate is 50%. I don't see anything there that makes me want to rush out and buy. I hope that helps."
He has a very good grasp of the science and has been mostly right about many companies. My $0.02.